Table 1.

Neurologic scores of BV-inoculated treated with topical ganciclovir or cidofovir

	Neurologic score
	Maximum	Survivors at 14 dpi
Topical ganciclovir
0% (control)	5 (5, 5); n = 23	no survivors
0.1%	5 (5, 5); n = 28	0 (0, 0); n = 6
0.3%	5 (5, 5); n = 28	0 (0, 0.5); n = 6
0.5%	5 (2, 5); n = 28	1.5 (0, 2); n = 11
1%	a3 (1, 5); n = 28	0.5 (0, 2); n = 19
3%	a1.75 (0, 2.9); n = 28	0 (0, 1); n = 28
5%	*0 (0, 1); n = 28	0 (0, 0); n = 28
% cidofovir
0% (control)	5 (5, 5); n = 15	no survivors
0.001%	5 (5, 5); n = 20	no survivors
0.003%	5 (5, 5); n = 20	0 (0, 0); n = 4
0.005%	5 (5, 5); n = 10	no survivors
0.01%	0.5 (0, 5); n = 20	0 (0, 0); n = 13
0.03%	a0 (0, 0); n = 20	0 (0, 0); n = 18
0.05%	a0 (0, 0); n = 10	0 (0, 0); n = 10
0.1%	a0 (0, 0.75); n = 20	0 (0, 0); n = 16
0.3%	a0 (0, 0); n = 20	0 (0, 0); n = 20
1%	a0 (0, 0); n = 9	0 (0, 0); n = 9
3%	a0 (0, 0); n = 9	0 (0, 0); n = 9
5%	a0 (0, 0); n = 9	0 (0, 0); n = 9

Data are presented as the median (lower quartile, upper quartile); number of mice in group.

^aValue is significantly (P < 0.05) different from maximal neurologic score of control mice.